Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.

Date issued
2015Journal title
Journal Of Clinical Oncology
Type of content
Publicación de congreso
